Related Experiment Videos
Where are all the novel antidepressants?
1Neuropharmacology Laboratory, Mayo Clinic, Mayo Foundation, Jacksonville, FL 32224, USA. richel@mayo.edu
Current Opinion in Investigational Drugs (London, England : 2000)
|January 31, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
European journal of pain (London, England)·2012
NT69L, a novel analgesic, shows synergy with morphine.
Brain research·2009
Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
Pharmacology, biochemistry, and behavior·2005
The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Behavioural brain research·2003
Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia.
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2001
Reporting disease control rates or clinical benefit rates in early clinical trials of anticancer agents: useful endpoint or hype?
Current opinion in investigational drugs (London, England : 2000)·2011
Abating progressive tissue injury and preserving function after CNS trauma: The role of inflammation modulatory therapies.
Current opinion in investigational drugs (London, England : 2000)·2010
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
Current opinion in investigational drugs (London, England : 2000)·2010
Tralokinumab, an anti-IL-13 mAb for the potential treatment of asthma and COPD.
Current opinion in investigational drugs (London, England : 2000)·2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's disease.
Current opinion in investigational drugs (London, England : 2000)·2010
Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Current opinion in investigational drugs (London, England : 2000)·2010
From incident response to system design: Japan's 2025 PMD Act drug-shortage reform.
Health policy (Amsterdam, Netherlands)·2026
Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013-19.
Health affairs (Project Hope)·2026
Efficacy and safety of pioglitazone in lichen planopilaris in comparison with hydroxychloroquine: Prospective non-inferiority study.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
What's in a name? reframing advanced Parkinson's disease as a multidimensional state.
Journal of neural transmission (Vienna, Austria : 1996)·2026